Literature DB >> 20172884

A comparison of voluntarily reported medication errors in intensive care and general care units.

S L Kane-Gill1, J G Kowiatek, R J Weber.   

Abstract

BACKGROUND: Few institutions currently track intensive care unit (ICU)-specific medication safety data. A comparison of medication error data for intensive care and general care units may determine if ICU-specific surveillance is needed.
OBJECTIVE: To compare the type, cause, contributing factors, level of staff initiating an error, medication use process node, drug classes and patient outcomes for voluntarily reported medication errors occurring in ICUs and general care units.
DESIGN: Retrospective evaluation of voluntarily reported medication errors over 4.5 years at a 647-bed academic medical centre containing greater than 120 ICU beds. Adult patients with a reported medication error in intensive care and general care units were included. Medication error data were compared for ICUs with general care units. MAIN MEASURES AND
RESULTS: There were a total of 3252 medication errors reported with 541 and 2711 occurring in ICUs and general care units, respectively. Primary types of medication errors were prescribing in the ICUs and omission in the general care units. Leading causes of medication errors were procedure/protocol not followed and knowledge deficit in the ICU and general care units. More frequently there was no contributing factor identified for medication errors in the ICUs. The top three drugs associated with medication errors in the ICUs were opioid analgesics, beta-lactam antimicrobials and blood coagulation modifiers compared with anti-asthma/bronchodilators, narcotic analgesics and vaccines in the general care units. The level of care provided after the error was observation increased/initiated in ICUs and no additional care in general care units. Prolonged hospitalisation was a result of medication errors in 1% of ICU cases and 0.4% of general care unit errors (p = 0.056). Medication errors were associated with harm in 12% and 6% of cases in the ICUs and general care units, respectively (p<0.001).
CONCLUSION: Type, contributing factors, drug classes and patient outcomes associated with voluntarily reported medication errors differ in intensive care and general care units so it is important to develop surveillance systems that analyse ICU-specific data allowing systematic changes for this patient population.

Entities:  

Mesh:

Year:  2010        PMID: 20172884     DOI: 10.1136/qshc.2008.027961

Source DB:  PubMed          Journal:  Qual Saf Health Care        ISSN: 1475-3898


  18 in total

1.  Multiple Intravenous Infusions Phase 2b: Laboratory Study.

Authors:  Sonia Pinkney; Mark Fan; Katherine Chan; Christine Koczmara; Christopher Colvin; Farzan Sasangohar; Caterina Masino; Anthony Easty; Patricia Trbovich
Journal:  Ont Health Technol Assess Ser       Date:  2014-05-01

2.  On the integration and standardization of medication error data: taxonomies, terminologies, causes and contributing factors.

Authors:  Ibrahim Adham Taib; Andrew Stuart McIntosh
Journal:  Ther Adv Drug Saf       Date:  2010-12

3.  Use of Text Searching for Trigger Words in Medical Records to Identify Adverse Drug Reactions within an Intensive Care Unit Discharge Summary.

Authors:  Sandra L Kane-Gill; Adam M MacLasco; Melissa I Saul; Tiffany R Politz Smith; Megan A Kloet; Catherine Kim; Ananth M Anthes; Pamela L Smithburger; Amy L Seybert
Journal:  Appl Clin Inform       Date:  2016-07-13       Impact factor: 2.342

4.  Voluntarily reported prescribing, monitoring and medication transfer errors in intensive care units in The Netherlands.

Authors:  B E Bosma; N G M Hunfeld; E Roobol-Meuwese; T Dijkstra; S M Coenradie; A Blenke; W Bult; P H G J Melief; M Perenboom-Van Dixhoorn; P M L A van den Bemt
Journal:  Int J Clin Pharm       Date:  2020-08-19

5.  A Multicenter Evaluation of Off-Label Medication Use and Associated Adverse Drug Reactions in Adult Medical ICUs.

Authors:  Pamela L Smithburger; Mitchell S Buckley; Mark A Culver; Sarah Sokol; Ishaq Lat; Steven M Handler; Levent Kirisci; Sandra L Kane-Gill
Journal:  Crit Care Med       Date:  2015-08       Impact factor: 7.598

6.  Analysis of risk factors for adverse drug events in critically ill patients*.

Authors:  Sandra L Kane-Gill; Levent Kirisci; Margaret M Verrico; Jeffrey M Rothschild
Journal:  Crit Care Med       Date:  2012-03       Impact factor: 7.598

Review 7.  An integrative review of drug errors in critical care.

Authors:  Caroline C MacFie; Simon V Baudouin; Peter B Messer
Journal:  J Intensive Care Soc       Date:  2015-10-14

8.  Drug-drug interactions in cardiac and cardiothoracic intensive care units: an analysis of patients in an academic medical centre in the US.

Authors:  Pamela L Smithburger; Sandra L Kane-Gill; Amy L Seybert
Journal:  Drug Saf       Date:  2010-10-01       Impact factor: 5.606

9.  Computerized detection of adverse drug reactions in the medical intensive care unit.

Authors:  Sandra L Kane-Gill; Shyam Visweswaran; Melissa I Saul; An-Kwok Ian Wong; Louis E Penrod; Steven M Handler
Journal:  Int J Med Inform       Date:  2011-05-31       Impact factor: 4.046

10.  Evaluation of an automated surveillance system using trigger alerts to prevent adverse drug events in the intensive care unit and general ward.

Authors:  John P DiPoto; Mitchell S Buckley; Sandra L Kane-Gill
Journal:  Drug Saf       Date:  2015-03       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.